Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Cohance Lifesciences Q1 Review: Brokerages Split After Earnings Slump — Check Potential Upside, Target Price

    3 hours ago

    Macquarie retained its Outperform rating on Cohance Lifesciences despite a weaker-than-expected June quarter, while Jefferies maintained Underperform as sales declines across businesses pushed EBITDA close to break-even.
    Click here to Read More
    Previous Article
    Berger Paints Q1 Review: Outlook Brightens For Q2, But Morgan Stanley Remains Cautious — Check Target Price
    Next Article
    तेज म्यूजिक पर विवाद; विक्रोली में चाकू से हमला, पिता और 14 साल के बेटे की मौत

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment